What Are the Challenges in Targeting Helper T Cells?
While targeting helper T cells holds promise, several challenges exist:
- Immune Evasion: Tumors can develop new ways to evade helper T cell-mediated immunity. - Side Effects: Enhancing the immune response can lead to autoimmune reactions where the immune system attacks normal tissues. - Heterogeneity: Different cancers and even different patients may respond variably to therapies targeting helper T cells.
